Nektar Therapeutics share price today

(NKTR)

Nektar Therapeutics share price is $0.93 & ₹79.03 as on 21 Dec 2024, 2.30 'hrs' IST

$0.93

▲

-0.01

(-1.35%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Nektar Therapeutics share price in Dollar and Rupees. Guide to invest in Nektar Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Nektar Therapeutics. Get details on the Indian mutual funds that are investing in Nektar Therapeutics. Get Analyst recommendations and forecasts along with all the Nektar Therapeutics's financials.

Nektar Therapeutics share price movements

Today's Low: $0.90
Today's High: $0.96
$0.93
3.23%
Downside
Day's Volatility :6.05%
Upside
2.92%
52 Weeks Low: $0.47
52 Weeks High: $1.93
$0.93
49.46%
Downside
52 Weeks Volatility :75.62%
Upside
51.76%

Nektar Therapeutics Returns

Period	Nektar Therapeutics	Sector (Health Care)	Index (Russel 2000)
3 Months	-22.64%	-11.1%	0.0%
6 Months	-20.66%	-6.0%	0.0%
1 Year	82.02%	2.7%	0.0%
3 Years	-94.1%	0.6%	-19.7%

Nektar Therapeutics Key Statistics

in dollars & INR

Previous Close	$0.941
Open	$0.96
Today's High	$0.958
Today's Low	$0.9
Market Capitalization	$173.6M
Today's Volume	$1.7M
52 Week High	$1.928
52 Week Low	$0.47
Revenue TTM	$93.1M
EBITDA	$-130.2M
Earnings Per Share (EPS)	$-0.84
Profit Margin	-180.7%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-161.63%

How to invest in Nektar Therapeutics from India?

It is very easy for Indian residents to invest directly in Nektar Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nektar Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nektar Therapeutics or NKTR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nektar Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nektar Therapeutics shares which would translate to 0.914 fractional shares of Nektar Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Nektar Therapeutics, in just a few clicks!

Returns in Nektar Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Nektar Therapeutics investment value today

Current value as on today

₹1,84,549

Returns

₹84,549

(+84.55%)

Returns from Nektar Therapeutics Stock

₹82,353 (+82.35%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Nektar Therapeutics

73%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Nektar Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 73% more investors are searching Nektar Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Nektar Therapeutics

Deep Track Capital, LP
8.63%
BlackRock Inc
8.22%
Vanguard Group Inc
7.11%
Eventide Asset Management, LLC
5.10%
Samlyn Capital, LLC
4.99%
Citadel Advisors Llc
3.77%

Analyst Recommendation on Nektar Therapeutics

Hold

0%Buy

55%Hold

44%Sell

Based on 9 Wall street analysts offering stock ratings for Nektar Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Nektar Therapeutics

What analysts predicted

Upside of 405.38%

Current:

$0.93

Target:

$4.70

Insights on Nektar Therapeutics

Price Movement
In the last 1 year, NKTR stock has moved up by 96.7%
Increasing Revenue
Revenue is up for the last 3 quarters, 21.63M → 24.12M (in $), with an average increase of 5.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -52.36M → -37.05M (in $), with an average increase of 41.3% per quarter
NKTR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 117.0%

Nektar Therapeutics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.2B	↑ 287.81%
Net Income	$681.3M	↓ 804.62%
Net Profit Margin	57.09%	↑ 88.51%

	FY19	Y/Y Change
Revenue	$114.6M	↓ 90.4%
Net Income	$-440.7M	↓ 164.68%
Net Profit Margin	-384.47%	↓ 441.56%

	FY20	Y/Y Change
Revenue	$152.9M	↑ 33.41%
Net Income	$-444.4M	↑ 0.86%
Net Profit Margin	-290.65%	↑ 93.82%

	FY21	Y/Y Change
Revenue	$101.9M	↓ 33.36%
Net Income	$-523.8M	↑ 17.86%
Net Profit Margin	-514.03%	↓ 223.38%

	FY22	Y/Y Change
Revenue	$92.1M	↓ 9.67%
Net Income	$-368.2M	↓ 29.71%
Net Profit Margin	-399.98%	↑ 114.05%

	FY23	Y/Y Change
Revenue	$90.1M	↓ 2.1%
Net Income	$-276.1M	↓ 25.03%
Net Profit Margin	-306.31%	↑ 93.67%

	Q2 FY23	Q/Q Change
Revenue	$20.5M	↓ 5.07%
Net Income	$-51.1M	↓ 62.69%
Net Profit Margin	-249.39%	↑ 385.13%

	Q3 FY23	Q/Q Change
Revenue	$24.1M	↑ 17.78%
Net Income	$-45.8M	↓ 10.34%
Net Profit Margin	-189.85%	↑ 59.54%

	Q4 FY23	Q/Q Change
Revenue	$23.9M	↓ 1.07%
Net Income	$-42.1M	↓ 8.2%
Net Profit Margin	-176.17%	↑ 13.68%

	Q1 FY24	Q/Q Change
Revenue	$21.6M	↓ 9.4%
Net Income	$-36.8M	↓ 12.54%
Net Profit Margin	-170.07%	↑ 6.1%

	Q2 FY24	Q/Q Change
Revenue	$23.5M	↑ 8.55%
Net Income	$-52.4M	↑ 42.28%
Net Profit Margin	-222.93%	↓ 52.86%

	Q3 FY24	Q/Q Change
Revenue	$24.1M	↑ 2.7%
Net Income	$-37.1M	↓ 29.23%
Net Profit Margin	-153.61%	↑ 69.32%

	FY18	Y/Y Change
Profit	$1.2B	↑ 321.74%

	FY19	Y/Y Change
Profit	$93.2M	↓ 92.02%

	FY20	Y/Y Change
Profit	$133.4M	↑ 43.11%

	FY21	Y/Y Change
Profit	$77.0M	↓ 42.29%

	FY22	Y/Y Change
Profit	$70.4M	↓ 8.56%

	FY23	Y/Y Change
Profit	$53.5M	↓ 24.06%

	Q2 FY23	Q/Q Change
Profit	$13.5M	↓ 7.08%

	Q3 FY23	Q/Q Change
Profit	$11.7M	↓ 13.27%

	Q4 FY23	Q/Q Change
Profit	$16.6M	↑ 41.74%

	Q1 FY24	Q/Q Change
Profit	$13.1M	↓ 21.06%

	Q2 FY24	Q/Q Change
Profit	$13.7M	↑ 4.91%

	Q3 FY24	Q/Q Change
Profit	$19.7M	↑ 43.2%

	FY18	Y/Y Change
Operating Cash Flow	$718.2M	↓ 993.15%
Investing Cash Flow	$-1.4B	↑ 4689.95%
Financing Cash Flow	$852.0M	↑ 1466.37%

	FY19	Y/Y Change
Operating Cash Flow	$-328.7M	↓ 145.76%
Investing Cash Flow	$206.9M	↓ 114.99%
Financing Cash Flow	$23.4M	↓ 97.26%

	FY20	Y/Y Change
Operating Cash Flow	$-313.3M	↓ 4.68%
Investing Cash Flow	$496.2M	↑ 139.85%
Financing Cash Flow	$-80.4M	↓ 444.05%

	FY21	Y/Y Change
Operating Cash Flow	$-412.7M	↑ 31.72%
Investing Cash Flow	$202.8M	↓ 59.14%
Financing Cash Flow	$36.2M	↓ 145.1%

	FY22	Y/Y Change
Operating Cash Flow	$-304.0M	↓ 26.33%
Investing Cash Flow	$365.8M	↑ 80.41%
Financing Cash Flow	$1.5M	↓ 95.84%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-51.5M	↓ 0.76%
Investing Cash Flow	$25.2M	↓ 38.0%
Financing Cash Flow	$18.0K	↑ 0.0%

Nektar Therapeutics Technicals Summary

Sell

Neutral

Buy

Nektar Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nektar Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nektar Therapeutics	-8.09%	-20.66%	82.02%	-94.1%	-95.75%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nektar Therapeutics	NA	NA	3.22	0.0	-1.62	-0.23	NA	0.27
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nektar Therapeutics	Hold	$173.6M	-95.75%	NA	-180.7%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Nektar Therapeutics

nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

Organization	Nektar Therapeutics
Employees	137
CEO	Mr. Howard W. Robin
Industry	Health Technology

Management People of Nektar Therapeutics

Name	Title
Mr. Howard W. Robin	CEO, President & Director
Ms. Sandra A. Gardiner	Chief Financial Officer
Mr. Mark A. Wilson J.D.	Senior VP, Chief Legal Officer & Secretary
Dr. Jonathan Zalevsky Ph.D.	Chief Research & Development Officer
Ms. Vivian Wu	Director of Investor Relations & Corporate Affairs
Mr. Robert Bacci	Senior Vice President of Human Resources & Facilities Operations
Ms. Jennifer Ruddock	Chief Business Officer
Dr. Mary Tagliaferri L.Ac., M.D.	Chief Medical Officer

Important FAQs about investing in Nektar Therapeutics from India :

What is Nektar Therapeutics share price today?

Nektar Therapeutics share price today stands at $0.93, Open: $0.96 ; Previous Close: $0.94 ; High: $0.96 ; Low: $0.90 ; 52 Week High: $1.93 ; 52 Week Low: $0.47. The stock opens at $0.96, after a previous close of $0.94. The stock reached a daily high of $0.96 and a low of $0.90, with a 52-week high of $1.93 and a 52-week low of $0.47.

Can Indians buy Nektar Therapeutics shares?

Yes, Indians can invest in the Nektar Therapeutics (NKTR) from India.

With INDmoney, you can buy Nektar Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Nektar Therapeutics at zero transaction cost.

How can I buy Nektar Therapeutics shares from India?

It is very easy to buy Nektar Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nektar Therapeutics be purchased?

Yes, you can buy fractional shares of Nektar Therapeutics with INDmoney app.

What are the documents required to start investing in Nektar Therapeutics stocks?

To start investing in Nektar Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.